(Q42281003)

19 October 2017

Is the dopaminergic system involved in the central effects of nicotine in mice? (English)

1 reference

19 October 2017

1 reference

0 references

M I Damaj

1

1 reference

PubMed ID

7870924

19 October 2017

B R Martin

series ordinal

2

1 reference

19 October 2017

1 January 1993

1 reference

19 October 2017

1 reference

19 October 2017

111

1 reference

19 October 2017

1

1 reference

19 October 2017

106-108

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02257415

19 October 2017

0 references

cites work

The effects of nicotine on locomotor activity in non-tolerant and tolerant rats

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02257415

Nicotine-induced antinociception in rats and mice: correlation with nicotine brain levels.

21 January 2018

1 reference

12 December 2020

Evidence for an involvement of D1 and D2 dopamine receptors in mediating nicotine-induced hyperactivity in rats

1 reference

12 December 2020

D1 and D2 receptor antagonists differently affect cocaine-induced locomotor hyperactivity in the mouse

1 reference

12 December 2020

Acute and chronic tolerance to nicotine measured by activity in rats

1 reference

12 December 2020

Selective dopamine antagonists reduce nicotine self-administration.

1 reference

12 December 2020

Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons.

1 reference

12 December 2020

Dopamine-dependent hyperactivity in the rat following manipulation of GABA mechanisms in the region of the nucleus accumbens

1 reference

12 December 2020

Antin ociceptive activity of nicotine

1 reference

12 December 2020

Nicotine-induced sensitization to ambulatory stimulant effect produced by daily administration into the ventral tegmental area and the nucleus accumbens in rats

1 reference

12 December 2020

In vivo release of [3H]gamma-aminobutyric acid in the rat neostriatum--I. Characterization and topographical heterogeneity of the effects of dopaminergic and cholinergic agents

1 reference

12 December 2020

Microinjections of a nicotinic agonist into dopamine terminal fields: effects on locomotion.

1 reference

12 December 2020

The effect of various neurohumoral modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone tests.

1 reference

12 December 2020

Pharmacological evaluation of the antagonism of nicotine's central effects by mecamylamine and pempidine.

1 reference

12 December 2020

Dopaminergic mechanisms in the locomotor stimulant effects of nicotine

1 reference

12 December 2020

Stereoselective nicotine-induced release of dopamine from striatal synaptosomes: concentration dependence and repetitive stimulation.

1 reference

12 December 2020

Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats.

1 reference

12 December 2020

Drugs acting on brain dopamine receptors: a conceptual re-evaluation five years after the first selective D-1 antagonist

1 reference

12 December 2020

The effects of nicotine on brain neurotransmitter systems

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02257415

1 reference

PubMed ID

7870924

Dimensions Publication ID

19 October 2017

0 references

1 reference

PubMed ID

7870924